A Pintus

602 total citations
13 papers, 436 citations indexed

About

A Pintus is a scholar working on Oncology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, A Pintus has authored 13 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 5 papers in Pathology and Forensic Medicine and 4 papers in Immunology. Recurrent topics in A Pintus's work include Viral-associated cancers and disorders (8 papers), Lymphoma Diagnosis and Treatment (5 papers) and Histiocytic Disorders and Treatments (2 papers). A Pintus is often cited by papers focused on Viral-associated cancers and disorders (8 papers), Lymphoma Diagnosis and Treatment (5 papers) and Histiocytic Disorders and Treatments (2 papers). A Pintus collaborates with scholars based in Italy and United States. A Pintus's co-authors include Robert C. Gallo, Barbara Ensoli, Joseph Sonnabend, Felipe Samaniego, R Gendelman, P. D. Markham, Yoh Watanabe, Kamil Kowalski, Licinio Contu and Robert J. Biggar and has published in prestigious journals such as Blood, JAIDS Journal of Acquired Immune Deficiency Syndromes and International Archives of Allergy and Immunology.

In The Last Decade

A Pintus

12 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Pintus Italy 7 351 163 126 119 104 13 436
Kathryn Lurain United States 14 489 1.4× 147 0.9× 73 0.6× 271 2.3× 111 1.1× 52 685
Manuel Almagro Spain 13 76 0.2× 119 0.7× 40 0.3× 94 0.8× 45 0.4× 49 473
Marianne Asso‐Bonnet France 8 104 0.3× 107 0.7× 63 0.5× 125 1.1× 54 0.5× 9 374
B Gorguet France 12 140 0.4× 63 0.4× 39 0.3× 155 1.3× 50 0.5× 34 347
H. C. Kwan China 7 307 0.9× 95 0.6× 138 1.1× 79 0.7× 16 0.2× 10 362
Sandra Elmore United States 11 294 0.8× 90 0.6× 69 0.5× 141 1.2× 17 0.2× 18 429
Yong‐sheng Zong China 10 505 1.4× 89 0.5× 90 0.7× 202 1.7× 60 0.6× 29 618
Louise Fearfield United Kingdom 12 208 0.6× 144 0.9× 35 0.3× 94 0.8× 25 0.2× 32 551
Robert Harper United States 4 224 0.6× 92 0.6× 103 0.8× 77 0.6× 23 0.2× 5 424
Todd S. Laughlin United States 13 104 0.3× 91 0.6× 28 0.2× 51 0.4× 39 0.4× 18 361

Countries citing papers authored by A Pintus

Since Specialization
Citations

This map shows the geographic impact of A Pintus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Pintus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Pintus more than expected).

Fields of papers citing papers by A Pintus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Pintus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Pintus. The network helps show where A Pintus may publish in the future.

Co-authorship network of co-authors of A Pintus

This figure shows the co-authorship network connecting the top 25 collaborators of A Pintus. A scholar is included among the top collaborators of A Pintus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Pintus. A Pintus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Contu, L., D. Cerimele, Del Giacco Gs, & A Pintus. (2015). Therapy of Kaposi�s Sarcoma. Antibiotics and chemotherapy/Antibiotica et chemotherapia. 38. 121–131.
3.
Engels, Eric A., Denise Whitby, Andrea Stossel, et al.. (2000). Identifying Human Herpesvirus 8 Infection: Performance Characteristics of Serologic Assays. JAIDS Journal of Acquired Immune Deficiency Syndromes. 23(4). 346–354. 65 indexed citations
4.
Cossu, Antonio, et al.. (2000). [Blue nevus of the uterine cervix: description of a case and review of the literature].. PubMed. 92(4). 278–83. 2 indexed citations
5.
Engels, Eric A., Denise Whitby, Andrea Stossel, et al.. (2000). Identifying Human Herpesvirus 8 Infection: Performance Characteristics of Serologic Assays. JAIDS Journal of Acquired Immune Deficiency Syndromes. 23(4). 346–354. 40 indexed citations
6.
Samaniego, Felipe, P. D. Markham, R Gendelman, et al.. (1998). Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.. PubMed. 152(6). 1433–43. 146 indexed citations
8.
Cerimele, D., et al.. (1987). HLA markers in skin cancer. 15. 1065–1066. 3 indexed citations
9.
Contu, L., et al.. (1987). The role of alpha-interferon in the therapy of Kaposi's sarcoma (AIDS and classic forms) and of cutaneous T-cell lymphomas.. 4 indexed citations
10.
Contu, L., D. Cerimele, A Pintus, Francesca Cottoni, & Giorgio La Nasa. (1984). HLA and Kaposi's sarcoma in Sardinia. Tissue Antigens. 23(4). 240–245. 46 indexed citations
11.
Cerimele, D., Carlo Carcassi, Giorgio La Nasa, et al.. (1984). Immunogenetic and immunological studies on classical Kaposi's Sarcoma. 12. 891–892. 6 indexed citations
12.
Pintus, A, et al.. (1980). beta 0-Thalassemia in association with Hb Leslie (alpha 2 beta 2 131Gln leads to O) in a Sardinian family.. PubMed. 4(2). 195–200. 3 indexed citations
13.
Carcassi, U, et al.. (1977). HLA Antigens and Erythrocyte Glucose-6-Phosphate Dehydrogenase (G-6-PD) Deficiency in Sardinia. International Archives of Allergy and Immunology. 54(3). 285–287. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026